Kinesiological / Dietary Supplement Intervention in Knee Osteoarthritis
NCT06269549
Summary
The goal of this clinical trial is to assess the effectiveness of dietary supplement combined with exercise in managing knee osteoarthritis (KOA). The main questions it aims to answer are: * Is adding a dietary supplement to exercise additionally effective in managing KOA? * Is adding exercise to the dietary supplement additionally effective in managing KOA? Participants will be given in three groups: 1. Real dietary supplement alone 2. Real dietary supplement with exercise 3. Placebo dietary supplement with exercise Investigators will compare groups 1 and 2, or 2 and 3, to answer the research questions. The hypothesis is that participants who receive the dietary supplement along with exercise will experience greater reduction in pain level, improved physical function, and enhanced quality of life compared to those who receive a placebo combined with exercise or dietary supplement alone.
Eligibility
Inclusion Criteria: * knee osteoarthritis of one or both knee * severity of knee osteoarthritis based on Kellgren-Lawrence radiographic grade 1-3 * knee pain between 4 and 7 (using a 0-10 scale) Exclusion Criteria: * Age \<55 years * Kellgren \& Lawrence grade 4 of knee osteoarthritis * Acute knee injuries within the last 6 months * Knee pain not associated with knee osteoarthritis * History of knee or hip endoprosthesis * Surgery on the back, hip, knee, ankle, or foot within the last 12 months * Health issues or musculoskeletal limitations affecting strength training and mobility more than knee pain (e.g., lower back pain, hip pain) * Rheumatoid arthritis, gout * Neurological conditions (Alzheimer's disease, Parkinson's disease, metabolic diseases affecting the nervous system) * Muscular or joint diseases/injuries affecting lower limb function (e.g., hip and/or ankle osteoarthritis, sprains, fractures) * Internal medical conditions (cardiovascular, pulmonary, oncological, diabetes with late complications - diabetic foot, neuropathies) affecting physical performance * Stroke or similar condition with consequences on motor skills and/or cognition (inability to provide consent) * Balance disorders, known vestibular system impairment * Body Mass Index \> 32 * Structured strength training exceeding 30 minutes per week * Corticosteroids and/or hyaluronic acid (intra-articular) use in the last 6 months * Individuals taking joint health dietary supplements, like glucosamine, chondroitin, or collagen, will need to halt use for at least 30 days before measurements to avoid affecting study outcomes
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06269549